If you are a member of the general public and not a healthcare professional, NOVELTY study investigator or AstraZeneca Medical employee, please CLICK HERE to see information tailored to you.

Useful links

Home > Publications & resources > General resources > Useful links

Below are resources that you may find useful to learn more about the NOVELTY study and general information about the treatment of asthma and COPD.

AstraZeneca Patient Reported Outcomes (PROs) (see ‘Therapeutic areas’ for Respiratory PROs)
Global Initiative for Asthma (GINA)
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Real-world research and its importance in respiratory medicine. Price D, Brussell G, Roche N, Freeman D, Chisolm A. Breathe 2015; 11: 26-38.
Integrating real-life studies in the global therapeutic research framework. Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, Papi A, Postma D, Thomas M, Brusselle G, Israel E, Rand C, Chisholm A, Price D; Respiratory Effectiveness Group. Lancet Respir Med 2013; 1: e29-30.

19 PARTICIPATING COUNTRIES^a

~12,000 ENROLLED PATIENTS^a

84% OF PATIENTS HAVE SPIROMETRY DATA^b

You are now leaving: http://aznoveltyproject.com/

By following this link you will be leaving the NOVELTY study website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to NOVELTY study